2019
Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection
Sangtani A, Wang C, Weaver A, Hoppman N, Kerr S, Abyzov A, Shridhar V, Staub J, Kocher J, Voss J, Podratz K, Wentzensen N, Kisiel J, Sherman M, Bakkum-Gamez J. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection. Gynecologic Oncology 2019, 156: 387-392. PMID: 31787246, PMCID: PMC7018609, DOI: 10.1016/j.ygyno.2019.11.028.Peer-Reviewed Original Research
2016
Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation
Druliner B, Rashtak S, Ruan X, Bae T, Vasmatzis N, O’Brien D, Johnson R, Felmlee-Devine D, Washechek-Aletto J, Basu N, Liu H, Smyrk T, Abyzov A, Boardman L. Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation. Translational Oncology 2016, 9: 280-286. PMID: 27567950, PMCID: PMC4941582, DOI: 10.1016/j.tranon.2016.06.002.Peer-Reviewed Original ResearchColorectal cancerResidual polypBiopsy-proven colorectal cancerEquivalent hazard ratiosEarly-stage diseaseSame disease stageRemnant polypsHazard ratioOverall survivalCancer Genome AtlasClinical coursePathologic characteristicsDisease stageMayo ClinicAdenomatous polypsColorectal carcinogenesisMalignant transformationCarcinoma transitionPolypsGenome AtlasGene expression profilesGenomic profilesWhole-genome sequencingCancerAge